Press release
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an immune system response that causes the inflamed skin and other symptoms.
Atopic dermatitis (eczema) symptoms include dry, cr*cked skin, itchiness, rash, bumps, on brown or black skin, oozing and crusting, thickened skin, darkening of the skin around the eyes, raw, sensitive skin from scratching.
Read more about Atopic Dermatitis - Drug Pipeline here: https://www.globalinsightservices.com/reports/atopic-dermatitis-drug-pipeline-landscape-2022/
Healthcare provider will diagnose eczema examining the skin. However, the following tests may be performed for confirmation, an allergy skin test, blood tests and a skin biopsy to distinguish one type of dermatitis from another.
Treatment of atopic dermatitis starts with moisturizing and self-care habits. These are sometimes combined with other treatments like medications and therapies. Medications including products applied to the skin, anti-infective drugs and anti-inflammatories. Therapies like wet dressings, light therapy and counselling may also help based on the severity.
There are many clinical trials ongoing in atopic dermatitis drug development. Some of the most promising trials are studying new treatments for atopic dermatitis, such as biologic drugs. Biologic drugs are made from living cells and are designed to target specific parts of the immune system. They have the potential to be more effective and have fewer side effects than traditional drugs. Other clinical trials are studying new ways to deliver existing treatments, such as through patches or creams.
To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31002/
Methodology:
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope:
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31002/
Key Players:
• 3SBio Inc
• AbbVie
• Aclaris Therapeutics, Inc.
• Akaal Pharma Pty Ltd
• Akesobio Australia Pty Ltd
• Allakos, Inc.
• Amgen
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis - Drug Pipeline Landscape, 2022 here
News-ID: 2721606 • Views: …
More Releases from Global Insight Services

Carbon Footprint Management Market Expected to Grow from $13.8 Billion in 2024 t …
The Carbon Footprint Management Market is witnessing remarkable growth, reflecting the global shift toward sustainability and environmental responsibility. This market focuses on solutions, services, and technologies designed to measure, monitor, and reduce carbon emissions across multiple industries. It includes carbon accounting software, lifecycle assessment tools, consulting services, and advanced technologies like carbon capture and storage. Organizations increasingly rely on these solutions to meet regulatory compliance, achieve sustainability targets, and enhance…

Breastfeeding Nutrition Market Expected to Grow from $50.9 Billion in 2024 to $1 …
The Breastfeeding Nutrition Market is witnessing remarkable growth, fueled by rising awareness of maternal and infant health worldwide. This market encompasses a diverse range of products, including infant formula, lactation supplements, breastfeeding accessories, and fortified foods, designed to enhance breast milk quality and maternal nutrition. With increasing emphasis on scientifically backed nutrition and natural ingredients, the market plays a crucial role in supporting the well-being of both mothers and infants.…

Radiopharmaceuticals Market Is Anticipated To Expand From $18.4 Billion In 2024 …
Market Overview
The Radiopharmaceuticals Market is rapidly transforming the healthcare landscape, offering innovative solutions for both diagnostics and therapeutics in nuclear medicine. Valued at $18.4 billion in 2024, this industry is projected to surge to $72 billion by 2034, registering an impressive CAGR of 14.6%. Radiopharmaceuticals are specialized compounds that combine a radioactive element with a pharmaceutical agent, enabling precise imaging and targeted treatment. The growing adoption of these agents in…

Zero Trust Security Market Is Anticipated To Expand From $47.1 Billion In 2024 T …
Market Overview
The Zero Trust Security Market is transforming the way organizations approach digital protection. Unlike traditional security frameworks that rely on perimeter defenses, Zero Trust operates on the principle of "never trust, always verify." Every user, device, and application must continuously prove its legitimacy before gaining access to critical resources. This model has gained traction as enterprises face increasingly complex cyber threats and adopt hybrid infrastructures that blend cloud and…
More Releases for Atopic
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Atopic Dermatitis Market Size By 2025?
The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Atopic Dermatitis Pipeline…
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result…
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger…
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”.
In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to…
Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018 - ResearchByMarkets …
"Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018", provides an overview of the Atopic Dermatitis (Atopic Eczema) (Dermatology) pipeline landscape.
Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from…